使用GUIDE-IT试验对LIFE-HF临床预测模型进行独立的外部验证
Ricky D Turgeon1,2, Nathaniel M Hawkins2, Mohsen Sadatsafavi1
1Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, University of British Columbia, Room 5523-2405 Wesbrook Mall, Vancouver, British Columbia, Canada V6T 1Z3.
ESC heart failure
|February 19, 2026
概括
对于心力衰竭 (HF) 的预后,LIFE-HF模型在北美队列中显示出良好的歧视,但预测不足的风险. 死亡率模型可能有助于决策,但复合模型需要进一步验证.
科学领域:
- 心脏病学 心脏病学
- 医学预测 医学预测
- 健康 结果 研究 研究 结果
背景情况:
- 准确的预后对于心力衰竭 (HF) 管理至关重要.
- LIFE-HF模型是预测HF结果的新工具.
- 需要对LIFE-HF模型进行独立的外部验证.
研究的目的:
- 在当代北美人口中对LIFE-HF模型进行外部验证.
- 评估LIFE-HF模型的性能,以预测一年内所有原因的死亡和死亡或HF住院的复合情况.
主要方法:
- 外部验证使用来自GUIDE-IT试验的患者级数据.
- 对歧视的评估 (AUROC) 和校准 (O/E比率,斜率,曲线).
- 使用决策曲线分析评估预测错误和临床净益处.
主要成果:
- 死亡率模型显示出良好的歧视 (AUROC 0.77),但预测不足和不合适.
- 复合模型显示了中度的歧视 (AUROC 0.69),预测不足和过拟合.
- 死亡率模型提供了净临床益处,与复合模型不同.
结论:
- LIFE-HF模型表现出良好的歧视性,但系统地低估了高风险HF患者的1年风险.
- 死亡率模型显示了支持基于风险的临床决策的潜力.
- 复合模型需要在临床应用之前进行额外的验证.
相关概念视频
Data Validation
6.4K
Data validation is an essential part of a comprehensive assessment. Validation is confirming or verifying and opening the door to gathering more assessment data as it clarifies vague or unclear data. The process of checking and verifying the collected information is called data validation. The primary purpose of data validation is to ensure data is as free from error, bias, and misinterpretation as possible.
Nursing assessment guides are generally based on holistic models rather than medical...
Nursing assessment guides are generally based on holistic models rather than medical...
6.4K
Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
Bioavailability Study Design: Healthy Subjects Versus Patients
248
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248


